Citadel Advisors »

Theravance Biopharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 155k 11.24
2023-09-30 $377k 44k 8.63
2023-06-30 $1.0M 97k 10.35
2023-03-31 $1.1M 104k 10.85
2022-12-31 $1.9M 166k 11.22
2022-06-30 $235k 26k 9.05
2022-03-31 $374k 39k 9.65
2021-12-31 $462k 42k 10.94
2021-09-30 $2.5M 340k 7.40
2021-03-31 $220k 11k 20.37
2020-09-30 $2.2M 149k 14.78
2020-06-30 $3.6M 171k 20.99
2020-03-31 $473k 21k 23.13
2019-12-31 $766k 30k 25.89
2019-06-30 $795k 49k 16.32
2019-03-31 $1.9M 85k 22.67
2018-12-31 $775k 30k 25.59
2018-09-30 $910k 28k 32.66
2018-06-30 $743k 33k 22.66
2017-03-31 $3.1M 85k 36.82
2015-12-31 $222k 14k 16.40
2015-03-31 $662k 38k 17.36
2014-12-31 $718k 48k 14.92
2014-09-30 $323k 14k 23.07
2014-06-30 $1.3M 40k 31.88